Inside Innovation

Funding from VCs for Seattle’s life science industry grew 266% during Q1 2021 in comparison with Q1 last year. This makes Seattle the fastest-growing life

Earlier this month, Icosavax, a Seattle-based biotech company that originally launched from the University of Washington, filed for IPO. Founded in 2017, Icosavax develops vaccines

Seattle continues to be an integral player in the fight against COVID-19, with local company HDT Bio announcing it will enter early-stage clinical trials in

Absci, a Vancouver-based startup, is the latest Washington biotech company to announce its intent to go public. The company has had a robust 2021 so

Seattle was recently named the top U.S. city for LGBTQ+ employees, beating out Chicago, Washington D.C., San Francisco and New York to take the number

Congratulations are in order for sponsor company Adaptive Biotechnologies, which made Puget Sound Business Journal’s list of 2021 Best Workplaces in Washington. The annual award

Nautilus Biotechnology recently raised $345 million via SPAC to fuel a new approach that could accelerate biomedical research and transform drug development. Propelled by this

Seattle-based law firm Perkins Coie is launching The Black Boardroom Initiative, which aims to grow the diversity of S&P 500 corporate boards by increasing the

An ultrapotent, second-generation COVID-19 vaccine candidate developed by the University of Washington Medicine’s Institute for Protein Design and South Korea-based SK bioscience received $173.4 million

Spokane-based Jubilant HollisterStier announced a $92 million expansion plan to its existing manufacturing lines, which will allow the company to increase capacity by 50%. The

Eliem Therapeutics raised $60 million in a Series B funding round to advance its pipeline of clinical and preclinical drugs, following closely on the heel

Seattle has long been known as a tech hub – but now, it’s poised for a life science boom. With lab space increasingly hard to